{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:40Z","timestamp":1740107320760,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00415-022-11379-2","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T12:02:46Z","timestamp":1664798566000},"page":"1147-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adult motor neuron disease death rates in Finland 1998\u20132019"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-9054","authenticated-orcid":false,"given":"Jussi O. T.","family":"Sipil\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manu","family":"Jokela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"11379_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41:118\u2013130. https:\/\/doi.org\/10.1159\/000351153","journal-title":"Neuroepidemiology"},{"key":"11379_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00415-019-09652-y","volume":"267","author":"L Xu","year":"2020","unstructured":"Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, Zhan S, Wang S (2020) Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 267:944\u2013953. https:\/\/doi.org\/10.1007\/s00415-019-09652-y","journal-title":"J Neurol"},{"key":"11379_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323\u2013330. https:\/\/doi.org\/10.1016\/S1474-4422(12)70043-1","journal-title":"Lancet Neurol"},{"key":"11379_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1034\/j.1600-0404.2001.00361.x","volume":"104","author":"P Maasilta","year":"2001","unstructured":"Maasilta P, Jokelainen M, L\u00f6yt\u00f6nen M, Sabel CE, Gatrell AC (2001) Mortality from amyotrophic lateral sclerosis in Finland, 1986\u20131995. Acta Neurol Scand 104:232\u2013235. https:\/\/doi.org\/10.1034\/j.1600-0404.2001.00361.x","journal-title":"Acta Neurol Scand"},{"key":"11379_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/gerona\/glaa224","volume":"76","author":"K Koivunen","year":"2021","unstructured":"Koivunen K, Sillanp\u00e4\u00e4 E, Munukka M, Portegijs E, Rantanen T (2021) Cohort differences in maximal physical performance: a comparison of 75- and 80-year-old men and women born 28 years apart. J Gerontol A Biol Sci Med Sci 76:1251\u20131259. https:\/\/doi.org\/10.1093\/gerona\/glaa224","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"11379_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40520-020-01702-0","volume":"33","author":"M Munukka","year":"2021","unstructured":"Munukka M, Koivunen K, von Bonsdorff M, Sipil\u00e4 S, Portegijs E, Ruoppila I, Rantanen T (2021) Birth cohort differences in cognitive performance in 75- and 80-year-olds\u2014a comparison of two cohorts over 28 years. Aging Clin Exp Res 33:57\u201365. https:\/\/doi.org\/10.1007\/s40520-020-01702-0","journal-title":"Aging Clin Exp Res"},{"key":"11379_CR7","unstructured":"Quality Description: Causes of death 2020 https:\/\/www.stat.fi\/til\/ksyyt\/2020\/ksyyt_2020_2021-12-10_laa_001_en.html. [accessed Aug 12, 2022]"},{"key":"11379_CR8","unstructured":"Lahti RA (2005) From findings to statistics: an assessment of Finnish medical cause-of-death information in relation to underlying-cause coding. Dissertation, University of Helsinki. https:\/\/helda.helsinki.fi\/handle\/10138\/20374"},{"key":"11379_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000321930","volume":"36","author":"B Marin","year":"2011","unstructured":"Marin B, Couratier P, Preux PM, Logroscino G (2011) Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 36:29\u201338. https:\/\/doi.org\/10.1159\/000321930","journal-title":"Neuroepidemiology"},{"key":"11379_CR10","unstructured":"Jokela M (2015) Late-onset spinal motor neuronopathy- a new neuromuscular disease. Dissertation, University of Turku. https:\/\/www.utupub.fi\/handle\/10024\/117735"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11379-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:09:14Z","timestamp":1675055354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["11379"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11379-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JOTS has received honoraria (Merck, Pfizer, Sanofi), consultancy fees (Medaffcon), travel grants and congress sponsorship (Abbvie, Orion Pharma, Merck Serono, Novartis) and holds shares (Orion Corporation). MJ has received honoraria from Sanofi and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}